GleamWall
中文EN

UHS UNIVERSAL HEALTH SERVICES INC

Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 352915 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY8.0%
TTM net income YoY6.3%
TTM EPS YoY13.7%
Revenue 3-yr CAGR9.4%
Net income 3-yr CAGR29.3%

Margins

Gross margin—
Operating margin10.8%
Net margin8.0%
FCF margin6.1%
EBITDA margin14.5%

Returns

ROE19.8%
ROA9.0%
ROIC (approx.)12.2%
Asset turnover1.13x

Leverage & solvency

Liabilities / assets55.0%
Debt / equity0.75x
Current ratio1.37x
Interest coverage11.34x

Cash quality & payout

Operating cash flow / net income1.41x
Accruals ratio-3.7%
Payout ratio3.3%
Capex / revenue5.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$4.73B$4.64B$4.50B$4.49B$4.50B$4.28B$4.10B$4.11B
Operating income$454.45M$516.67M$502.86M$517.23M$521.69M$500.27M$454.82M$472.49M
Interest expense$56.28M$39.91M$37.13M$42.22M$38.43M$35.36M$40.06M$39.72M
Pretax income$413.91M$479.13M$469.12M$581.44M$496.89M$473.38M$420.43M$438.31M
Income tax$100.58M$114.54M$110.44M$133.60M$117.78M$110.77M$98.80M$101.26M
Net income$308.68M$358.45M$348.68M$445.94M$372.96M$353.22M$316.68M$332.40M
EBITDA$629.29M$684.01M$658.29M$680.57M$676.75M$652.27M$603.17M$619.27M
EPS (basic)5.256.015.71—5.925.494.87—
EPS (diluted)5.225.985.65—5.865.434.80—
Dividends declared per share0.200.200.200.200.200.200.200.20
Weighted avg. shares (diluted)59.15M59.91M61.67M—63.66M64.99M66.04M—
Balance sheet
Cash & equivalents$168.75M$138.80M$119.03M$137.80M$112.89M$137.59M$126.75M$125.98M
Receivables$2.81B$2.80B$2.75B$2.60B$2.59B$2.30B$2.41B$2.18B
Current assets$3.68B$3.68B$3.50B$3.41B$3.26B$2.99B$3.08B$2.82B
PP&E, net$7.22B$7.14B$7.06B$7.01B$6.97B$6.88B$6.70B$6.57B
Goodwill$4.74B$3.98B$3.98B$3.99B$3.99B$3.98B$3.95B$3.93B
Intangibles———$75.88M———$76.27M
Total assets$17.19B$15.94B$15.68B$15.53B$15.34B$14.99B$14.88B$14.47B
Current liabilities$2.69B$3.30B$3.24B$3.24B$3.16B$2.32B$2.33B$2.21B
Short-term debt$79.81M$771.91M$756.24M$748.16M$740.19M$40.90M$40.41M$40.06M
Long-term debt$5.63B$4.08B$3.95B$4.00B$3.95B$4.54B$4.61B$4.46B
Total debt$5.71B$4.85B$4.71B$4.75B$4.69B$4.58B$4.65B$4.50B
Total liabilities$9.44B$8.28B$8.08B$8.12B$8.05B$7.84B$7.99B$7.71B
Shareholders' equity$7.60B$7.51B$7.46B$7.28B$7.17B$7.03B$6.79B$6.67B
Net debt$5.54B$4.71B$4.59B$4.61B$4.58B$4.45B$4.52B$4.38B
Cash flow statement
Operating cash flow$636.56M$443.30M$401.63M$574.69M$380.68M$548.98M$360.05M$658.44M
Capital expenditure$214.94M$227.63M$217.16M$281.22M$228.89M$266.01M$239.03M$245.94M
Free cash flow$421.61M$215.67M$184.47M$293.47M$151.79M$282.96M$121.02M$412.49M
Investing cash flow-$1.21B-$234.23M-$197.58M-$223.97M-$269.41M-$305.94M-$271.30M-$207.99M
Financing cash flow$605.73M-$189.49M-$221.89M-$296.13M-$134.52M-$227.65M-$91.42M-$426.76M
Depreciation & amortization$174.84M$167.34M$155.43M$163.33M$155.06M$152.00M$148.34M$146.78M
Stock-based compensation$26.36M$22.91M$22.50M$25.10M$24.88M$24.11M$21.59M$26.62M
Dividends paid$11.79M$11.79M$12.97M$12.37M$12.47M$12.90M$13.53M$13.04M
Share buybacks$245.26M$320.75M$163.85M$352.01M$237.40M$155.16M$223.38M$250.17M

Free plan shows the latest 8 periods; Pro shows all 70 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.